+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk factors that influence survival in kidney transplant recipients with post-transplant lymphoproliferative disease A multivariate analysis



Risk factors that influence survival in kidney transplant recipients with post-transplant lymphoproliferative disease A multivariate analysis



Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 178A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035673508

Download citation: RISBibTeXText


Related references

Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. American Journal of Transplantation 5(4 Pt 1): 775-780, 2005

Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients. Kidney International 94(4): 809-817, 2018

Analysis of risk factors for post-transplant lymphoproliferative disease in pediatric lung transplant recipients with cystic fibrosis. Pediatric Research 43(4 Part 2): 131A, 1998

Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort. Transplant Infectious Disease 20(1):, 2018

Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. British Journal of Surgery 88(10): 1330-1334, 2001

Incidence and risk factors for post-transplant lymphoproliferative disorder among renal transplant recipients. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 564A, 2002

Risk factors for post transplant lymphoproliferative disorder ptld in renal transplant recipients. Journal of the American Society of Nephrology 2(3): 795, 1991

Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases. Transplant Infectious Disease 7(3-4): 133-136, 2006

Incidence and risk factors of EBV related post transplant lymphoproliferative diseases in paediatric liver transplant recipients treated with tacrolimus. Hepatology 26(4 Part 2): 343A, 1997

Predictive value of cytokine genotyping for the risk of post transplant lymphoproliferative disease in solid organ transplant recipients. Human Immunology 61(Suppl. 2): S138, 2000

Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections. Transplant Infectious Disease 18(3): 415-422, 2016

The use of objective case ascertainment to identify risk factors for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder in pediatric liver transplant recipients. Hepatology 36(4 Part 2): 662A, 2002

Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV) - seronegative adult liver transplant recipients. Transplant International 7(Suppl. S1): 235-237, 1994

Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients. Transplant International 7(Suppl. 1): S235-S237, 1994

Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatric Transplantation 5(5): 359-364, 2001